Company intelligence / Profile preview

Ringo

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Ring Biotechnology specializes in the development, manufacturing, and commercialization of rapid test kits for food safety and animal diagnostics. The company has received multiple certifications including ISO9001, ISO13485, GMP for veterinary reagents, GSP certificate, AOAC-RI certification for its KangarooSci Aerobic Count Plate, and FSSAI approval in India for its Aflatoxin M1 Rapid Test Kit. As of late 2022–2023 it employs over 300 staff with significant production capacity.

Therapeutic areas: OtherInfectious Diseases
Modalities: Diagnostic kit (for food safety and animal health)Veterinary diagnostic reagents
Industry: Veterinary

Partnerships

No major pharmaceutical or biotech partnerships disclosed publicly.

Beyond the preview

Go deeper on Ringo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ringo.

Explore the full profile